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Repeated amphetamine use produces an enduring sensitization of brain dopamine (DA) systems and behavior. Repeated 
exposure to stress can also produce sensitization, and amphetamine and stress may be interchangeable in this regard. There 
is, however, enormous individual variation in the susceptibility to sensitization by either stimulants or stress. The purpose of 
the present study was to determine if endogenous gonadal hormones contribute to individual variation in the sensitization of 
stereotyped behaviors, locomotion or regional brain monoamine metabolism. It was found that removal of testicular hormones 
by castration of male rats facilitated the behavioral sensitization produced by either repeated amphetamine treatment or repeated 
restraint stress, but ovariectomy of female rats was without effect. Prior exposure to amphetamine enhanced striatal homovanillic 
acid (HVA) levels and dihydroxyphenylacetic acid to DA and HVA to DA ratios in intact female, ovariectomized female and 
castrated male rats, but not gonadally-intact male rats. As a group, intact males were particularly heterogeneous because they 
were divisible into two neurochemically distinct subgroups based on their degree of behavioral sensitization, and the other groups 
were not. It is suggested that individual differences in the sensitization of brain DA systems and behavior produced by repeated 
exposure to amphetamine or stress may be due in part to individual differences in the concentration of a testicular hormone. 
INTRODUCTION 
The  repeated,  intermit tent  adminis t ra t ion  o f  
a m p h e t a m i n e  ( A M P H )  p r o d u c e s  a progress ive  
and  endur ing  e n h a n c e m e n t  in behav io r  elicited by 
subsequent  exposure  to A M P H ,  a p h e n o m e n o n  
called behaviora l  sensi t izat ion 2°,36,44,45,55,67, and  
this is a c c o m p a n i e d  by  endur ing  changes  in brain  
d o p a m i n e  ( D A )  sys tems 59. M o s t  animals  show 
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sensitization, but there is also enormous indi- 
vidual variation in the susceptibility to sensiti- 
zation 41'a7'53"66. In exploring what factors might 
contribute to this variation we previously found 
sex 'differences in behavioral sensitization, and 
some of its neurochemical co r r e l a t e s  14,15,55,61. 
Most sex differences in behavior have been 
attributed to the action of gonadal steroid hor- 
mones, either during an early organizational 
period or in adulthood 24, and the sex difference in 
behavioral sensitization may be due to a testicular 
hormone in adult males. This is because adult 
male rats gonadectomized (GDX) prior to 
AMPH treatment show greater sensitization of 
AMPH-induced rotational behavior than intact 
males, and do not differ from intact or GDX 
females  55,61. However, the contribution of 
gonadal hormones to the sensitization of other 
behaviors produced by AMPH is not known. It 
is possible that gonadal hormones affect the sensi- 
tization of stereotyped behavior and locomotor 
activity differently than rotational behavior, 
because AMPH produces its wide array of be- 
havioral effects by altering activity in anatomically 
and functionally heterogeneous brain catechol- 
amine sys t ems  19'3°'35'73. Therefore, experiments 
were conducted to determine the effects of endo- 
genous gonadal hormones on the AMPH-induced 
sensitization of stereotyped behavior and loco- 
motion, and on associated changes in regional 
brain DA metabolism. 
In addition, it has been suggested that the 
enduring effects of AMPH may not be unique to 
the psychopharmacology of AMPH, but due to its 
action as a stressor 1"3'21'52. For example, repeated 
exposure to a variety of stressors enhances the 
behavioral response to a subsequent injection of 
A M P H  4'28'57. Conversely, sensitization to 
AMPH enhances behavioral and neurochemical 
responses to subsequent s t ress  4'62. Therefore, the 
influence of sex and gonadal hormones on the 
behavioral sensitization produced by repeated ex- 
posure to restraint stress was also examined. It 
was hypothesized that if AMPH and stress are 
interchangeable in producing sensitization, then 
sex and gonadal hormones should have similar 
effects on the behavioral sensitization produced 
by previous exposure to either AMPH or stress. 
EXPERIMENT 1: THE INFLUENCE OF ENDO- 
GENOUS GONADAL HORMONES ON THE SENSITI- 
ZATION OF LOCOMOTION, STEREOTYPED BE- 
HAVIOR AND BRAIN MONOAMINES PRODUCED 




The experiments were conducted with adult 
male and female Holtzman rats 
(Sprague-Dawley-derived; Holtzman Co., Madi- 
son, WI) weighing 250-300 g at the start of the 
experiment. All animals were housed individually 
in wire-hanging cages in a room that was 
maintained on a normal 14:10 light:dark cycle 
(lights on at 08.00 h). Food and water were freely 
available. All testing was conducted between 
09.00 and 16.00 h. 
Apparatus 
Motor activity was measured using automated 
activity monitors. These consisted of wire-hang- 
ing cages (41 × 24 × 18 cm) equipped with two 
pairs of infrared photocell emitters and detectors 
situated along the long axis of each cage. The 
photocells were mounted 2.3 cm above the cage 
floor and 15 cm apart from each other, dividing 
the cage into a central area in which there was no 
photocell beam, and two 13 cm long areas to the 
extreme right and left of the cage in which the 
presence of a rat would result in disruption of the 
photocell beam. Disruption of a photocell beam 
was detected by a microcomputer (Commodore 
VIC20) that recorded the total number of photo- 
cell beam interruptions during each 5-min inter- 
val. Breaking one photocell beam registered a 
single count. However, another count could not 
be registered from the same beam until the second 
photocell beam at the other end of the cage was 
disrupted. Thus, activity counts in this apparatus 
reflect locomotion from one side of the cage to the 
other. 
Ratings of stereotyped behavior 
Stereotyped behavior was assessed visually 
using two different rating scales. The 9-point scale 
described by Ellinwood and B alster 23 was used to 
estimate overall stereotypy. On this scale, 
1 = asleep; 2 = inactive; 3 = normal in-place 
activity; 4 = normal, alert, active; 5 = hyper- 
active; 6 = slow patterned stereotypy; 7 = fast 
patterned stereotypy; 8 = restricted stereotypy; 
and 9 = dyskinetic-reactive. In addition, various 
components of stereotypy, including repetitive 
sniffing, repetitive movements of the head and 
limbs, and repetitive oral behaviors (licking or 
biting) were individually rated according to their 
intensity (1 = mild, 2 = moderate, 3 = intense) 
and duration (1 = discontinuous, 2 = continu- 
ous), as described by Rebec and Sega154. For each 
measure the intensity and duration scores were 
multiplied together to yield a single stereotypy 
score at each time interval. 
Procedure 
To determine the influence of endogenous 
gonadal hormones on the development of sensiti- 
zation, female and male rats were either gonadec- 
tomized (GDX), or received a sham operation 
under ether anesthesia. Ten days later the animals 
were habituated to the activity monitors for 
8-12 h, and again 2 days later. Beginning two 
weeks after surgery the animals received an intra- 
peritoneal (i.p.) injection of D-amphetamine sul- 
fate (AMPH) dissolved in 0.9~o saline once every 
3 days for a total of 10 injections, followed 3 days 
later by a single i.p. injection of saline (1 ml/kg). 
Intact male rats ( n -  15) received 3.0 mg/kg 
AMPH (weight of the salt) on all 10 treatment 
days. The remaining 3 groups received a lower 
dose of AMPH than intact males, because tes- 
ticular hormones accelerate AMPH metabolism, 
resulting in lower brain levels of AMPH in intact 
males than in females or GDX males given the 
same systemic dose 7,18. On the basis of previous 
studies in which striatal and whole brain concen- 
trations of AMPH were measured at various 
points in time after the i.p. administration of a 
wide range of AMPH doses (1-10 mg/kg), we 
determined that 2.6 mg/kg (i.p.) produces the 
same brain concentration of AMPH in intact 
female, GDX female and GDX male rats as does 
3.0 mg/kg in intact males 7 (also unpublished 
studies). Thus, for the first 9 days of drug treat- 
71 
ment intact females (n = 15), GDX females 
(n = 15) and GDX males (n = 15) received 
2.6 mg/kg AMPH. On the 10th drug treatment 
day animals in these latter 3 groups received a 
lower challenge dose of AMPH (2.0 mg/kg). This 
provided an even more conservative test, because 
this dose would produce lower brain levels of 
AMPH in females and GDX males than in intact 
males given 3.0 mg/kg. 
Behavior was not monitored following every 
AMPH treatment, but only following the 1 st, 2nd, 
3rd, 4th, 7th and 10th treatments (test days). On 
test days the animals were placed in the activity 
monitors and allowed 1 h to habituate. Then they 
received the injection of AMPH, and locomotor 
activity counts were cumulated over 5-min inter- 
vals for the next 2 h. Stereotyped behavior was 
rated during 45-s observation periods at 10 and 
20 min following the injection, and every 20 min 
thereafter for 2 h, by an observer blind to group 
membership. On AMPH treatment days when 
behavior was not monitored (treatment days 6, 8, 
and 9) the animals were immediately replaced 
into their home cage following the injection. 
Three additional groups were included to 
address the role of drug-environment condition- 
ing in the sensitization of locomotion and stereo- 
typy 64"72. Each of these control groups consisted 
of intact female (n = 10 or 15) and GDX male 
(n = 10 or 15) rats, because it was hypothesized 
that: (1) intact and GDX females would not differ 
in their behavioral response to repeated AMPH 
treatment; and (2)these groups would show 
robust behavioral sensitization. A group of 
'saline-contror (S) animals were treated exactly 
as the experimental animals described above, 
except they received injections of saline in place 
of AMPH for the fh'st 9 days of drug adminis- 
tration, and 2.0 mg/kg AMPH on the tenth day. 
A 'pseudoconditioned' (Ps) group received the 
same AMPH treatment as described for the 
experimental animals, but did not receive AMPH 
in the test environment. On the 1st, 2nd, 3rd, 4th 
and 7th test days the pseudoconditioned animals 
received saline in the activity monitors and 
2.6 mg/kg AMPH just prior to being placed back 
in their home cages. On the tenth day, these 
animals received 2.0 mg/kg AMPH in the test 
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cage. Thus, pseudoconditioned rats received the 
first 9 injections of AMPH in their home cages 
and only the tenth injection (challenge) in the test 
cage. Finally, 'non-handled-control' (NH) ani- 
mals were left undisturbed in their home cages 
until the 10th test day, at which time they also 
received the challenge dose of AMPH (2.0 mg/kg) 
in the test cages. Locomotion and stereotypy were 
recorded as described for the experimental ani- 
mals. 
Neurochemical procedures and methods 
Eight to 9 days following the last AMPH treat- 
ment, all experimental animals, and additional 
male and female rats (intact and GDX; 
n = 10/treatment condition) that were either pre- 
treated with saline (one injection every 3 days for 
a total of 10 injections) or non-handled, were 
killed by decapitation. The brains were rapidly 
removed ( < 40 s) and dissected in ice-cold saline. 
The frontal cortex, nucleus accumbens and 
striatum were removed using a procedure similar 
to that described by Heffner et al. zS, but with the 
following modifications. (1)The frontal cortex 
included only the medial tissue anterior to the 
genu of the corpus callosum; and (2) the nucleus 
accumbens and striatum were removed using 
2 mm and 3 mm diameter micropunches, respec- 
tively. The tissue was immediately weighed and 
placed into tubes containing either 250 #1 (frontal 
cortex, nucleus accumbens), or 300/~1 (striatum) 
of 0.05 N perchloric acid, with dihydroxybenzyl- 
amine (2 ng/10 #1 and 4 ng/10/A, respectively) 
added as an internal standard. The tissue samples 
were homogenized and centrifuged at 5000 g for 
45 min at 2-4  °C. The supernatant was then 
filtered using 0.2/~m regenerated cellulose mem- 
brane filters and stored in vials at - 2 0  ° C. 
Tissue concentrations of dopamine (DA), 3,4- 
dihydroxyphenylacetic acid (DOPAC), homo- 
vanillic acid (HVA), 5-hydroxytryptamine (5-HT; 
serotonin), and 5-hydroxyindoleacetic acid 
(5-HIAA) were assayed by high-performance 
liquid chromatography (HPLC) with electro- 
chemical detection. Briefly, the HPLC system 
employed a Brownlee MPLC reverse phase C-18 
column and an LC-4 electrochemical detector 
with a glassy carbon electrode (Bioanalytical 
Systems). The detector potential was set at 
+ 0.74 V against an Ag/AgC1 reference electrode. 
The mobile phase was a citric acid-NaHPO4 
solution (pH 3.35) containing 25-30 mg/l octyl 
sulfonate and 8-10 ~o methanol. Concentration s 
of each neurochemical were standardized across 
assays. 
Data analysis 
Non-parametric statistical techniques were 
used to analyze the stereotypy rating scores, 
including Profile analyses 49 and Mann-Whitney 
U-tests for independent a priori comparisons. 
Locomotor scores and the neurochemical data 
were analyzed using parametric statistics that 
included one- or two-way analyses of variance for 
repeated measures, and the Student's t-test for 
individual a priori comparisons. All comparisons 
were based on two-tailed probabilities, unless 
otherwise noted. The F-values for group and inter- 
action effects are indicated by Fg and Fi, respec- 
tively. Separate statistical analyses were con- 
ducted on the stereotypy scores obtained over test 
sessions 1-7, versus those obtained during the 
10th session, because of the difference between 
the sensitizing and challenge doses of AMPH. 
Results 
Stereotyped behavior: response to the first injection 
The first injection of AMPH produced greater 
overall stereotypy in intact females, GDX females 
and GDX males than in intact males (Fig. 1A: 
U = 3 4 ,  P = 0 . 0 0 1 ;  U = 6 8 ,  P = 0 . 0 6 ;  U = 6 7 ,  
P = 0.058, respectively). The former 3 groups did 
not differ from each other. For stereotyped 
sniffing behavior (Fig. 1C), the comparison with 
intact males was significant for intact females 
(U-- 38, P = 0.002), but not for GDX females 
(U--86.5,  P =  0.3) or GDX males ( U =  88, 
P = 0.3). Most animals did not show repetitive 
head and limb movements following the first in- 
jection of AMPH (Fig. 1B). 
Test sessions 1- 7 
Over the first 7 treatment days the repeated 
intermittent administration of AMPH produced a 
progressive increase in stereotyped behavior, in- 
cluding repetitive head and limb movements and 
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Fig. 1. The effects ofgonadectonay (GDX) on the sensitiza- 
tion of amphetamine (AMPH)-induced stereotyped behavior 
(panel A: overall stereotypy; panel B: repetitive head 
and limb movements; panel C: stereotyped sniffing). The 
points represent the mean (+ S.E.M.) stereotypy scores 
cumulated over each 2-h test session. Intact male rats (solid 
squares) received 3.0 mg/kg AMPH on all test sessions. 
Intact females (solid circles), GDX females (open circles) 
and GDX males (open squares) received 2.6 mg/kg AMPH 
during the first 9 days of AMPH treatment (test sessions 
1,2,3,4 and 7 are shown), but on the 10th session received a 
lower challenge dose of AMPH (2.0 mg/kg; see Methods for 
rationale). A single acute injection of the challenge dose of 
AMPH did not behaviorally distinguish independent groups 
of intact female or GDX male rats from intact male rats (see 
small symbols at far left of each panel). * Significant inter- 
action terms, differs from all other groups, P < 0.05; * Inter- 
action effect, differs from intact males, P = 0.017 (see text for 
details). Note that intact females, GDX females and GDX 
males show more robust sensitization than intact males. 
sniffing, in all 4 groups (effect of  test session, all 
P ' s  < 0.001). Most  animals did not  show stereo- 
typed licking or biting with the doses used here. 
To determine if endogenous gonadal  hormones  
influenced the sensitization of  stereotyped be- 
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haviors, intact male and female rats were com- 
pared with G D X  rats. Fig. 1A illustrates that  
G D X  males showed a greater enhancement  in 
overall stereotypy than intact males, as indicated 
by a significant group x test session interaction 
(profile analysis: Fi -- 3.66, P = 0.018). In female 
rats, however, there was no significant effect of  
gonadectomy on the sensitization of  overall 
stereotypy (Fg = 1.7, P = 0.2; b'i = 0.3). Because 
intact and G D X  females did not  differ, these 
groups were pooled to test for sex differences in 
the sensitization of  overall stereotyped behavior. 
Females showed a greater enhancement  in overall 
stereotypy than intact males (i.e. the profdes are 
not parallel, ~ = 2.84, P = 0.036), but did not  
differ from G D X  males (Fg = 1.09, P = 0.38; 
Fi = 0.3). 
There were similar differences in the sensiti- 
zation of  repetitive head and limb movements  
(Fig. 1B). A profile analysis over test sessions 1-7 
revealed no significant differences between intact 
and G D X  female rats (Fg = 1.39, P =  0.3; 
/q = 0.3), and therefore their da ta  were pooled. 
As illustrated in Fig. 1B, both female and G D X  
male rats showed a greater enhancement  in repeti- 
tive head and limb movements  than did intact 
male rats ( F i =  3.66, P =  0.012; F i =  4.99, 
P = 0.004, respectively). Again, female and G D X  
male animals did not  differ from each other 
(Fg = 0.7; Fi = 1.23, e = 0.3). 
Fig. 1C illustrates that G D X  males also 
showed more robust  sensitization o f  stereotyped 
sniffing than did intact males ( F i =  3.67, 
P = 0.017). There was a non-significant trend for 
intact females to have greater stereotyped snilTmg 
scores than G D X  females (Fg = 3.26, P = 0.08), 
and therefore the data  for the female groups were 
not  pooled for the compar ison with males. Both 
intact and G D X  female rats showed more sniffing 
behavior than intact males (group effects: 
F ' s  = 39.5 and 13.8, P < 0.001), but  the inter- 
action terms were not  significant. The two female 
groups did not  differ significantly from G D X  
males. 
Challenge test (test session 1 O) 
Fig. 1A (far right) shows that even during the 
challenge test, when intact females, G D X  females 
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and GDX males received 2.0 mg/kg and intact 
males 3.0 mg/kg, the former 3 groups showed sig- 
nificantly greater overall stereotyped behavior 
than intact males (U = 65, P = 0.048; U = 65.5, 
P = 0.05; U = 50.5, P = 0.01, respectively), but 
did not differ from each other. Likewise, during 
the challenge test stereotyped sniffing behavior 
(Fig. 1C) was significantly greater in these 
3 groups than in intact males (intact females: 
U = 64.5, P = 0.046; GDX females: U = 51.5, 
P = 0.011; GDX males: U =  34.5, P = 0.001). A 
single acute injection of this dose did not dis- 
tinguish the stereotyped behavior of intact female, 
GDX male and intact male rats (small symbols to 
the far left of Fig. 1A-C). 
Analysis of repetitive head and limb move- 
ments during the challenge test revealed a dif- 
ferent pattern of effects than did analysis of overall 
stereotypy or stereotyped snilTmg (Fig. 1B). It 
might not have been expected that the lower chal- 
lenge injection of AMPH would come to dis- 
tinguish head and limb movements in the 4 groups 
of animals, because there were no initial dif- 
ferences among the 4 groups (see above). How- 
ever, even when challenged with 2.0 mg/kg GDX 
males had significantly higher repetitive head and 
limb movement scores than did intact males 
( U =  64, P =  0.044), intact females ( U =  65, 
P = 0.048), or GDX females ( U =  55.5, 
P = 0.017), and these latter 3 groups did not differ 
from each other (all P's > 0.39). 
Influence of conditioning variables 
To determine if repeatedly pairing AMPH with 
the test environment (activity monitors) in- 
fluenced the sensitization of stereotypy, the 'sen- 
sitized' groups of intact female and GDX male 
rats described above were each compared with a 
pseudoconditioned control group that previously 
received saline in the testing environment, and 
AMPH in their home cages. On the 10th day of 
AMPH treatment, both groups received the chal- 
lenge dose in the test cages. Fig. 2 shows that 
there was no difference between rats that received 
AMPH in the test cage (A) and pseudocondi- 
tioned (Ps) animals in overall stereotypy, repeti- 
tive head and limb movements, or sniffing be- 
havior. 
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Fig. 2. The mean (+  S.E.M.) stereotypy scores cumulated 
over a 2-h test session following the administration of 
2.0 mg/kg AMPH to groups of intact female and castrated 
(CAST) male rats that  differed in their previous history of 
drug-test environment pairing. AMPH-pretreated animals 
(A; n = 15/group) are the same animals shown in Fig. 1, and 
they received 5 previous injections of 2.6 mg/kg AMPH in the 
test chambers. Pseudoconditioned rats (Ps; n = 10/group) 
received the same treatment as AMPH-pretreated animals, 
except they received saline in the test environment and 
AMPH two h later in their home cage (i.e. AMPH was not 
paired with the test environment). Saline-control animals (S; 
n = 10/group) received repeated injections of saline in the 
test environment, but no AMPH. Non-handled control ani- 
mals (NH; n = 15/group) received no previous experience in 
the test environment, and no injections. The data  illustrated 
were obtained when all animals received a challenge injection 
of 2.0 mg/kg of AMPH on the 10th test session. Note that  
there was no difference between A and Ps animals, or S and 
NH animals on any of the stereotypy rating scales. However, 
the 'sensitized' animals (A plus Ps) had significantly greater 
stereotypy scores than control (S plus NH)  animals 
(* = P < 0.001). 
Fig. 2 also illustrates that previous experience 
in the testing environment in association with the 
injection procedure did not contribute to the 
development of sensitization. A saline control (S) 
group did not differ from non-handled control 
(NH) animals in their response to an acute injec- 
tion of the challenge dose ofAMPH (P's > 0.35). 
However, when the pooled data for sensitized and 
pseudoconditioned animals are compared with 
the pooled data of saline- and non-handled-con- 
trol animals (Fig. 2), it is clear that pretreatment 
with AMPH in either female or GDX male ani- 
mals produced a robust enhancement in overall 
stereotyped behavior, repetitive movements of the 
head and limbs, and sniffing behavior (all 
P-values < 0.001). Finally, an injection of saline 
given 3 days following the last test with AMPH 
did not produce stereotyped behavior. 
Locomotor activity (crossovers) 
Effects of the first injection of AMPH 
Fig. 3 (panel A) illustrates the effects of 
gonadectomy on the time course of locomotor 
activity (i.e. movements from one end of the cage 
to the other, or crossovers) in both male 
(column 1) and female (column 2) rats following 
the first injection of AMPH. Panel G illustrates 
the effects of a subsequent injection of saline. The 
first injection of AMPH enhanced locomotion in 
all 4groups of animals (compare panels A 
and G), but the 4 groups did not differ from each 
other on this measure (two-way ANOVA's com- 
paring each group with each other group). 
Effects of repeated exposure to AMPH 
With subsequent injections of AMPH (Fig. 3, 
panels B-E) a different pattern of behavior 
emerged. Compared with the response to the first 
AMPH injection, the time course of locomotion 
following the second injection showed an inter- 
mediate phase during which there was a signifi- 
cant reduction in locomotor activity (test 
session x time interaction: all P's < 0.006). 
Direct observation of the animals confn'med that 
this reduction was due to the presence of inter- 
mittent episodes of stereotyped behavior (i.e. 
stereotypy phase). Following the 3rd, 4th and 7th 
injections (panels C-E), this multiphasic pattern 
of behavior, consisting of an early and late period 
of enhanced locomotion and an intermediate 
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period of continuous stereotypy during which 
locomotion was greatly reduced, became progres- 
sively more pronounced. 
With repeated AMPH injections all 4 groups of 
animals developed this multiphasic pattern of 
behavior to some extent, but there were also 
significant group differences. Panel 1C (Fig. 3) 
illustrates that following the third injection of 
AMPH both intact and GDX males showed a 
stereotypy phase of reduced locomotion, but the 
stereotypy phase was longer-lasting in GDX 
males than in intact males, as indicated by a 
significant interaction. Individual comparisons 
comparing the number of crossovers made during 
each 5-min interval in intact and GDX males 
confirmed that the interaction was due entirely to 
the greater decrease in the number of crossovers 
made by GDX males during the 60-90 min 
period following the AMPH injection. By the 
seventh AMPH injection, GDX males not only 
had a longer-lasting stereotypy phase than intact 
males, but showed more focused stereotyped 
behavior than intact males, as reflected by the 
greater reduction in activity during the entire inter- 
mediate period (see panel 1E). That the intact 
males were more hyperactive during the test 
session is also indicated by an average overall 
stereotypy rating of about 5 ('hyperactive'), versus 
an average rating of close to 7 ('fast patterned 
stereotypy') for GDX males (Fig. 1). 
In contrast, intact and GDX female rats 
(column 2, Fig. 3) showed an almost identical 
change in their locomotor response across 
repeated test sessions (all ANOVA's non-signifi- 
cant). The data for the two female groups were 
pooled to test for sex differences in the locomotor 
response to repeated AMPH injections. When 
compared to intact males, females showed both a 
more intense and longer-lasting stereotypy phase 
of reduced locomotion following the 3rd, 4th and 
7th AMPH injections (columns 1 and2, 
panels C-E), as reflected by significant inter- 
action effects (F ' s=  1.79-2.42, P ' s < 0 . 0 1 -  
0.001); also compare the stereotypy ratings. 
In summary, analysis of the change in locomo- 
tor activity between the 1st and 7th injections of 
AMPH yielded the same pattern of group dif- 
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Fig. 3. Columns 1-2: the average number  of photocell interruptions (crossovers) during each of 24 five-min intervals following 
the administration of A M P H  or saline, in intact and gonadectomized (GDX) male and female rats. Panels A - F  show the number  
of crossovers made following the 1st, 2nd, 3rd, 4th and 10th injections of AMPH,  respectively. Panel G shows the number  of 
crossovers made following an injection of saline, which was given 3 -4  days following the last day of AMPH treatment. Panel A 
also shows the locomotor response in a group of non-handled G D X  male rats that  received only one acute injection of the lower 
challenge dose of AMPH (small dotted line; also shown in column 3, panel F). Note that  this latter group did not differ from 
intact males given their first injection of AMPH. The groups consist of the same animals as described in Fig. 1 (also see text). 
Significant differences between intact and G D X  animals are indicated by an asterisk. The F-values and probability values are 
also shown (Fg = group effect; Fi = interaction effect). Note that  G D X  males did not differ from intact males following the first 
injection of AMPH,  but with repeated AMPH treatment they came to do so. The G D X  females did not differ from intact females 
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Intact female, GD X  female and GDX male rats 
all showed more robust changes in behavior with 
repeated exposure to AMPH than did intact 
males, and the former 3 groups did not differ from 
each other. 
Challenge test 
There were similar effects of gonadectomy on 
locomotor activity during the 10th AMPH test, at 
which time intact female, GDX female and GDX 
male rats received the lower challenge dose of 
AMPH.  Again, intact and GDX males differed, 
as reflected by a significant group x time inter- 
action (Fig. 3, panel IF). Individual comparisons 
at each 5-min interval showed that GDX males 
had a pre-stereotypy phase of increased loco- 
motion (first 5-10 min following AMPH)  and a 
stereotypy phase of decreased locomotion that 
were greater than in intact males. However, the 
post-stereotypy phase of hyperactivity was com- 
parable in the two male groups. In addition, it 
should be noted that an independent group of 
GDX males given a single acute injection of 
2.0 mg/kg (challenge dose) did not differ signifi- 
cantly from intact males on test session 1 (small 
dotted line in panel 1A). In contrast, intact and 
GDX females showed an almost identical pattern 
of locomotion during the challenge test (all 
F 's  < 0.4). 
Influence of conditioning variables 
The effects of a challenge injection of A M P H  
on pseudoconditioned, saline-pretreated and 
non-handled control rats are shown in Fig. 3 
(columns 3 and 4, panel  F). The data for sen- 
sitized animals shown in columns 1 and 2 are 
reproduced in columns 3 and 4 (group A) respec- 
tively, for ease of comparison. 
It is clear from Fig. 3 that pseudoconditioned 
(Ps) animals did not differ from sensitized (A) 
animals during the challenge test (GDX males: 
F g = 2 . 9 1 ,  P = 0 . 1 ;  F i =  1.26, P = 0 . 2 ;  Intact 
females: F 's  < 1.0). It was not necessary, there- 
fore, to pair A M P H  administration with the test 
environment to produce the changes in locomotor 
activity described above. The pseudoconditioned 
and the normally sensitized groups (A) differed 
from both saline-pretreated and non-handled 
control animals (Fi's = 3.04-10.75, all P <  
0.001). Saline-pretreated GDX males did not 
differ from non-handled GDX males (panel 3G), 
but saline-pretreated females did show more loco- 
motion than non-handled females (Fi = 1.63, 
P = 0.034). 
Finally, there was no effect of GDX in males or 
females on the locomotor response to an injection 
of saline (Fig. 3, panels 1G and 2G), although 
females were more active than males (P < 0.001). 
More importantly, the saline 'challenge' did not 
produce an increase in locomotion comparable to 
that produced by AMPH.  Direct observation of 
the rats confirmed that the absence of locomotion 
following saline was not due to the presence of 
stereotypy, as no animal received an overall 
stereotypy rating greater than 4 ('normal, alert, 
active') during the 2-h test session. 
Neurochemical results 
Dopaminergic indices. Table I shows the con- 
centration of DA, DOPAC and HVA in the 
striatum, nucleus accumbens and medial frontal 
cortex for all 4 groups. There were no differences 
between saline-pretreated and non-handled con- 
trol animals, and therefore these two groups were 
pooled (control) for comparison with AMPH-  
pretreated animals. Intact female, GDX female, 
at any point in time. Columns 3-4: the effects of drug-environment conditioning on changes in the time course of locomotor 
activity (mean number of crossovers per 24 five-min intervals) in intact female and GDX male rats. During the 1st, 2nd, 3rd, 
4th and 7th day of drug treatment pseudoconditioned (Ps) and saline-pretreated (S) animals received saline in the test cage, and 
the number of crossovers for each of 24 five-min intervals are shown in Panels A-E. The pseudoconditioned animals received 
AMPH (2.6 mg/kg) in their home cage following each of these test sessions, and during the 5th, 6th, 8th and 9th days of drug 
treatment. On the 10th treatment day, these groups, and a group of non-handled control animals (NH), were administered a 
challenge injection of AMPH (2.0 mg/kg) in the test cage (panel F). For purposes of comparison, panel F also shows the data 
for AMPH-pretreated intact females and GDX males displayed in columns 1-2, panel F. Panel G illustrates the effects of a 
subsequent injection of saline administered to pseudoconditioned and saline-pretreated animals 3-4 days following the AMPH 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































striatal HVA concentrations, relative to control 
animals (Table I). Although the concentration of 
HVA in the nucleus accumbens was also elevated 
in these groups, the difference was statistically 
significant only for G D X  females (t = 3.08, 
P = 0.005). In contrast, A M P H  pretreatment had 
no measurable effect on striatal or nucleus 
accumbens HVA concentrations in intact male 
rats (t = 0.03-0.35). Consistent with previous 
reports (ref. 59 for review), there were no changes 
in basal concentration of DA or DOPAC in any 
brain region, except for a significant enhancement 
in nucleus accumbens DOPAC concentrations in 
AMPH-pretreated intact females (Table I). 
The ratio of DA metabolite to DA concentra- 
tions is thought to be a sensitive index of DA 
metabolism under some experimental condi- 
tions s'4°'71, and therefore DOPAC/DA and 
HVA/DA ratios were calculated to further 
examine the effects of  A M P H  pretreatment on 
DA metabolism. There were no significant dif- 
ferences in DOPAC/DA or HVA/DA ratios 
between saline-pretreated and non-handled con- 
trol animals in any brain region, except the striatal 
DOPAC/DA ratio tended to be higher in saline- 
pretreated than non-handled G D X  male rats 
(Fig. 4; t = 1.95, P -- 0.087). Therefore, except in 
this latter instance, data for the two control 
groups were pooled for comparison with AMPH-  
pretreated animals. Fig. 4 illustrates the effects of 
repeated A M P H  treatment on striatal DA 
metabolism, as indicated by metabolite/DA 
ratios. A M P H  pretreatment significantly in- 
creased striatal DA metabolism in intact female, 
G D X  female and G D X  male rats, as estimated by 
DOPAC/DA ratios (Fig. 4A: intact females: 
t-- 2.08, P = 0.049; G D X  females: t = 2.44, 
P =  0.023; G D X  males: A vs NH,  t = 2.19, 
P =  0.04, although A vs S, t =  0.31), and 
HVA/DA ratios (Fig. 4B: t = 2.33, P = 0.029; 
t = 2.44, P = 0.023; t = 2.98, P = 0.007, respec- 
tively). In contrast, A M P H  pretreatment had no 
effect on striatal DA metabolism in intact male 
rats (Fig. 4; DOPAC/DA:  t - -0 .3 ;  HVA/DA: 
t = 0.8). 
Repeated A M P H  treatment had no significant 
effect on basal DA metabolism in the nucleus 
accumbens or frontal cortex, except nucleus 
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Fig. 4. The mean (+ S.E.M.) striatal DOPAC/DA and 
HVA/DA ratios for AMPH-pretreated (A) and control (C) 
intact female, GDX female, intact male and GDX male rats 
(from the left). Data from saline-pretreated and non-handled 
animals were pooled to form the control groups. The 
DOPAC/DA ratios are shown separately in saline-pretreated 
(S) and non-handled (NH) GDX males, because only in this 
group was there a tendency for these two control groups to 
differ (t= 1.95, P =  0.087). Striatal DOPAC/DA and 
HVA/DA ratios were significantly elevated in the AMPH- 
pretreated intact females, GDX females and GDX males 
(* = significantly different from the control group, P < 0.05; 
* differs from non-handled controls, P = 0.04; two-tailed Stu- 
dent's t-tests). AMPH pretreatment had no effect on the DA 
metabolite to DA ratios in intact males. Group n's given in 
Table I. DA, dopamine; DOPAC, dihydroxyphenylacetic 
acid; HVA, homovanillic acid. 
accumbens HVA/DA ratios were significantly 
enhanced in AMPH-pretreated G D X  female rats 
(0.072 + 0.003 vs 0.057 + 0.002; t = 3.72, 
P = o . o o l ) .  
Serotoninergic indices. The concentrations of 
serotonin (5-HT), its metabolite, 5-HIAA, and 
5-HIAA/5-HT ratios in the nucleus accumbens, 
striatum and frontal cortex of AMPH-pretreated 
and control animals were determined (data not 
shown). The ratio of 5-HIAA to 5-HT has been 
reported to be a good index of serotonin utili- 
and G D X  male rats that were pretreated with 
A M P H  showed a significant increase in the 
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zation 68. There was no influence of saline-pre- 
treatment on any of the neurochemical measures, 
and therefore the data for saline-pretreated and 
non-handled control animals were pooled. There 
were no differences between AMPH-pretreated 
and control animals on any measure of serotonin 
activity, with one exception. AMPH-pretreated 
G D X  male rats had a significantly elevated stria- 
tal 5-HIAA/5-HT ratio (t = 2.55, P = 0.018). 
Although there were no statistical differences 
between AMPH-pretreated and control animals 
when each of the 4groups were compared 
separately, AMPH-pretreated intact females, 
G D X  females and G D X  males, (i.e. the three 
groups showing the most robust behavioral sensi- 
tization) consistently had higher 5-HIAA concen- 
trations and 5-HIAA/5-HT ratios than controls. 
When these 3 groups were pooled, the difference 
between AMPH-pretreated and control animals 
was statistically significant for both measures of 
serotonin activity in the striatum (5-HIAA: 
t = 2.02, P = 0.047; 5-HIAA/5-HT: t = 3.06, 
P = 0.003) and nucleus accumbens (5-HIAA: 
t = 2.67, P = 0.009; 5-HIAA/5-HT: t = 2.06, 
P = 0.043; all df  = 73). 
Subgroup analyses 
The animals in each group were subdivided into 
subgroups consisting of: (1)animals which 
showed a strong multiphasic pattern of behavior 
following the last injection of AMPH,  as de- 
scribed by Segal and Mandel167; i.e. an initial 
period of enhanced locomotion, followed by a 
period in which locomotion was absent (the 
stereotypy phase) and a post-stereotypy period of 
heightened locomotion; and (2)animals that did 
not show intense focused stereotypy, as indicated 
by a period in which locomotion was completely 
absent. For convenience, the former groups will 
be referred to as 'low activity groups' (LO) and the 
latter groups as 'high activity groups' (HI). It is 
presumed that the HI groups (least focused 
stereotypy) are less sensitized than the LO groups 
(most focused stereotypy). Only after animals 
were placed into one of these subgroups was the 
neurochemical data re-examined. 
Fig. 5 (panels A - D )  shows the activity counts 
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Fig. 5. The mean locomotor activity counts (photocell beam 
disruptions) over 24 five-min intervals following the last 
injection of amphetamine (10th test session) in intact female 
(panel A), gonadectomized (GDX) female (panel B), intact 
male (panel C) and GDX male (panel D) rats. These groups 
were subdivided into subgroups showing relatively low levels 
of locomotor activity (L, focused stereotypy) and those show- 
ing relatively high levels of locomotor activity (H, less focused 
stereotypy; see text). Panel E shows the locomotor activity 
for the H and L intact male subgroups following the first 
injection of amphetamine. Note that these two subgroups did 
not differ in their behavioral response to amphetamine 
following their initial exposure to the drug. Panel F shows the 
mean ( + S.E.M.) striatal DOPAC/DA ratios for each of the 
high activity (H) and low activity (L) subgroups. Note that 
there is a significant difference (* = P < 0.01) between the 
intact male H and L subgroups, but no differences between 
any of the other subgroups. Group n's: Male H(5), L(10); 
GDX male H(4), L(l l ) ;  Female H(7), L(8); GDX female 
H(7), L(8). 
GDX females (Fig. 5B), intact males (Fig. 5C) 
and G D X  males (Fig. 5D) during the last test 
session. Of course, the HI and LO subgroups are 
all highly statistically different, because they were 
selected to be maximally different. It is interesting, 
however, that for intact females, G D X  females 
and G D X  males even the HI activity subgroups 
showed some reduction in locomotion during the 
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period when the LO groups show the most 
focused stereotypy (i.e. no locomotion). In con- 
trast, HI activity intact male animals did not show 
any comparable reduction in locomotion 
(Fig. 5C). It appears that intact males were more 
clearly subdivisible into two very distinct 
subgroups on the basis of this behavioral measure 
than were intact females, GDX females or GDX 
males. Fig. 5 (panel E) also shows that the intact 
male subgroups did not differ in their behavioral 
response to the first injection of AMPH (nor did 
any of the other subgroups), supporting the notion 
that LO activity animals were more highly 
sensitized than HI activity animals. That is, only 
after repeated exposure to AMPH did the two 
groups differentiate. 
Striatal DOPAC/DA ratios for HI and LO 
activity intact males, intact females, GDX males 
and GDX females are shown in Fig. 5 (panel F). 
It should be kept in mind that the neurochemical 
data were obtained 8-9 days after the last injec- 
tion of AMPH, and when animals were in a 
non-drugged state. It can be seen in Fig. 5F that 
for intact males the LO and HI activity subgroups 
were neurochemically distinct, with the former 
group having significantly higher DOPAC/DA 
ratios (t = 2.84, P -- 0.014). In contrast, there was 
no difference in striatal DOPAC/DA ratios 
between LO and HI activity subgroups for intact 
females, GDX females or GDX males. There 
were no significant differences between any 
subgroups in nucleus accumbens or frontal cortex 
DOPAC/DA ratios. 
EXPERIMENT 2: THE INFLUENCE OF ENDO- 
GENOUS GONADAL HORMONES ON THE BE- 
HAVIORAL SENSITIZATION PRODUCED BY RE- 
PEATED INTERMITTENT RESTRAINT STRESS 
Method 
Pilot studies were conducted with intact female 
rats to determine if repeated restraint stress (2, 4 
or 10 consecutive days for 3 h each day) would 
produce enduring changes in the locomotion or 
stereotypy produced by a subsequent injection of 
AMPH (2.0, 2.5 or 5.0 mg/kg). After establishing 
that behavioral changes were indeed produced 
with this 'cross-sensitization' paradigm (also see 
ref. 28), the influence of endogenous gonadal hor- 
mones on the development of sensitization to re- 
peated restraint stress was studied. 
Two weeks after GDX or a sham operation, 
male and female rats received one of three treat- 
ments: (1) 5 consecutive days of restraint stress 
(n=  15/group); (2) 15consecutive days of 
restraint stress (n = 15/group); or (3)no treat- 
ment (n = 15/group). Restraint stress consisted of 
individually wrapping each rat in a cloth towel 
and then leaving it undisturbed in a lighted open 
area for 3 h each day. Animals in the no treatment 
control group were left undisturbed in their home 
cages. Ten days after the last restraint stress 
session all animals were tested for AMPH- 
induced stereotyped behavior, much as described 
above. Pilot studies showed that 3.5mg/kg 
AMPH elicited a behavioral response that was 
maximally sensitive to the effects of previous 
restraint stress. Therefore, intact females, GDX 
females and GDX males all received 3.5 mg/kg 
AMPH, and intact males received 4.0 mg/kg 
AMPH. Intact males received a higher dose for 
the reasons cited above 7. Stereotyped behavior 
was rated during a 45-s observation period every 
10 min following the injection, for 2.5 h, by two 




Fig. 6 (panels A - D )  shows the overall stereo- 
typy scores for each rating interval over the 2.5-h 
period following AMPH administration in previ- 
ously restrained and control animals. Profile 
analyses 49 of the time course were conducted 
comparing each treatment group (5 or 15 days of 
restraint) with its respective control group (0 days 
restraint). Previously restrained intact female, 
GDX female and GDX male rats had signifi- 
cantly higher stereotypy scores over the 2.5-h test 
session than did their respective control groups 
(all main effects: 5-day restraint groups: F = 4.73, 
P = 0 . 0 3 8 ;  F = 4 . 9 4 ,  P = 0 . 0 3 5 ;  F=4 .04 ,  
P = 0.05; 15-day restraint groups: F =  14.5, 
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Fig. 6. The sensitization of amphetamine-induced stereotypy 
produced by repeated exposure to daily restraint stress. 
Panels A - D  show the mean overall stereotypy scores for 
each of 14 ten-min intervals following an injection of 
amphetamine in animals that received either 5 or 15 daily 
sessions of restraint stress 10 days prior to the injection of 
AMPH, or animals that received no restraint stress ('0'; 
non-handled controls). The inserts in Panels A - D  show the 
mean ( + S.E.M.) stereotypy scores cumulated over the entire 
2.5-h test session in these same groups of animals. The 
restrained groups were each compared with their respective 
control group (profile analyses: ap=  0.07; *P<0.05;  
**P < 0.01; Mann-Whitney U-tests: *P < 0.05; **P < 0.01). 
Panels E and F illustrate the effects of repeated restraint 
stress on the sensitization of AMPH-induced repetitive head 
and limb movements and stereotyped sniffing, respectively. 
The bars indicate the mean stereotypy scores cumulated over 
the 2.5-h test session, and the lines represent the S.E.M. 
Dotted bars, 0 days of restraint (controls); striped bars, 
5 days of restraint; solid bars, 15 days of restraint. The 
restrained groups were each compared with their respective 
control group. (One-tailed Mann-Whitney U-tests: 
ap = 0.06; *P < 0.05; **P < 0.01; see text for details.) 
P = 0.007, respectively). In contrast, overall 
stereotypy scores in intact male rats were not 
affected by 5 days of previous restraint (F = 0.9). 
Furthermore, after 15daily restraint sessions 
there was only a non-significant tendency for 
elevated stereotypy scores in intact males 
(F-- 3.56, P = 0.07). One-tailed Mann-Whitney 
U-tests comparing the cumulative overall stereo- 
typy scores for the entire 2.5-h test session show- 
ed exactly the same pattern of effects as the profile 
analyses (Fig. 6; insets on panels A-D) .  
The effects of prior restraint stress on repetitive 
head and limb movements produced by A M P H  
were similar as for overall stereotypy scores 
(Fig. 6E). Five restraint sessions enhanced 
AMPH-induced repetitive head and limb move- 
ments in intact females, G D X  females and G D X  
males, relative to their respective control animals 
(one-tailed Mann-Whitney U-tests: U = 76, 
P = 0 . 0 6 5 ;  U=71 .5 ,  P = 0 . 0 4 4 ;  U=54 .5 ,  
P = 0.008), but was without effect in intact male 
rats ( U =  91, P = 0.2). However, 15 daily 
restraint sessions enhanced head and limb move- 
ments in all 4 groups, relative to their respective 
control groups (intact females: U = 66.5, 
P = 0.028; G D X  females: U = 66, P = 0.026; 
intact males: U = 39, P = 0.001; GDX males: 
U = 48.5, P = 0.004; all one-tailed tests). 
Analyses of stereotyped sniffing behavior 
revealed a different pattern of effects than did 
overall stereotypy or repetitive head and limb 
movements. Fig. 6F shows that both 5 and 
15 days of previous restraint stress enhanced 
stereotyped sniffing scores in all groups (intact 
females: 5days,  U =  75.5, P =  0.062; 15days, 
U =  56, P = 0.009; G D X  females: 5 days, 
U-- 66,P = 0.025; 15 days, U = 36.5,P = 0.001; 
intact males: 5 days, U =  37.5, P = 0.001; 
15days, U = 2 5 . 5 ,  P < 0 . 0 0 1 ;  G D X  males: 
5 days, U = 49.5, P = 0.004; 15 days, U = 62.5, 
P = 0.019; all one-tailed tests). Thus, for intact 
males stereotyped sniffing behavior was more 
sensitive to the effects of previous restraint stress 
than the other measures of stereotyped behavior. 
However, it should be noted that several of the 
intact female control rats received the maximum 
rating for sniffing (i.e. a score of 6) for the intervals 
during which stereotypy was most intense, sug- 
gesting a possible 'ceiling effect'. 
Finally, stereotypy ratings made by the two 
observers were compared to determine inter-rater 
reliability. The observers' ratings were highly 
correlated for each of the stereotypy measures. 
The correlation coefficients for the cumulative 
2.5-h rating scores for overall stereotypy, repeti- 
tive head and limb movements, and stereotyped 
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sniffing were + 0.98, + 0.97 and 0.97, respec- 
tively. 
DISCUSSION 
Three questions regarding the sensitization of 
stereotyped behavior, locomotion and brain 
monoamines were addressed. (1)Are sex dif- 
ferences in AMPH sensitization related to sex 
differences in circulating levels of gonadal hor- 
mones? (2)How are neural correlates of be- 
havioral sensitization influenced by sex and/or 
gonadal hormones? (3)Do sex and/or gonadal 
hormones influence the sensitization produced by 
repeated restraint stress in a similar manner as 
they do sensitization to AMPH? Each of these 
issues will be discussed in turn. 
Effects of  endogenous gonadal hormones on be- 
havioral sensitization to A M P H  
It was previously reported that female rats are 
more susceptible to behavioral sensitization than 
males 14'15'55"61, and this sex difference was repli- 
cated here. In addition, it was found that sex 
differences in sensitization appear to be largely 
due to sex differences in the circulating levels of 
male gonadal hormones. In males removal of 
endogenous gonadal hormones by gonadectomy 
(GDX) produced a significant enhancement in 
the sensitization of overall stereotypy, stereotyped 
sniffing, stereotyped repetitive head and limb 
movements, and AMPH-induced locomotor ac- 
tivity (relative to intact males). In contrast, GDX 
did not affect behavioral sensitization in female 
rats. These results, and the results of previous 
studies in which rotational behavior was quanti- 
fied 55"61, suggest that testicular secretions in 
adulthood retard the development of sensitization 
produced by repeated intermittent injections of 
AMPH. 
It is interesting that in contrast to the effects 
reported here, ovarian, and not testicular hor- 
mones seem to modulate some of the acute effects 
of AMPH. For example, in female rats GDX 
attenuates AMPH-induced rotational behav- 
ior 5,13, and AMPH-stimulated striatal DA release 
in vitro 6. However, GDX has no effect on either 
of these measures in males 6"13. Therefore, the 
effects of gonadal hormones on the acute be- 
havioral and neurochemical response to AMPH 
may be very different to their effects on neuroplas- 
tic adaptations to repeated AMPH treatment. 
Androgens affect AMPH metabolism 7,34,46, 
and therefore, it is important to consider whether 
the effect of GDX on sensitization described here 
is due to pharmacokinetic differences between the 
groups. It is difficult to totally control for phar- 
macokinetic variables, but the available evidence 
suggests these cannot account for the present 
results, for the following reasons. (1) In this, and 
in previous studies 11,15,55,61 the systemic dose of 
AMPH was titrated so that brain levels of AMPH 
would be equivalent in intact, as well as in GDX, 
males and females 7 (also J.B. Becker, unpub- 
lished studies). Furthermore, the difference 
between the intact males and the other 3 groups 
was present even when the intact females, GDX 
females and GDX males received a lower 
challenge dose of AMPH (also see refs. 14, 15). 
(2) For the ratings of overall stereotypy and repe- 
titive head and limb movements (Fig. 1) there 
were significant group by test session interactions 
(profile analyses). This indicates that the females 
and GDX males differed from intact males in the 
rate of  change in behavior with repeated AMPH 
treatment. Intact males were not just uniformly 
less responsive at all points in time. (3) Perhaps 
most convincing are the data on locomotor 
activity. There was no difference between the 
4 groups on this measure following the first in- 
jection of AMPH, but with repeated exposure the 
groups differentiated. This provides further 
strong evidence that the groups differed in the 
susceptibility to sensitization (i.e. the propensity to 
change), and not just in AMPH metabolism or the 
acute response to AMPH 56. 
It is also unlikely that drug-environment con- 
ditioning 51"64'72 played a major role in the sensiti- 
zation reported here. Pseudoconditioned animals, 
which received saline in the test environment and 
AMPH in their home cage, did not differ from 
animals that received most of their AMPH in- 
jections in the test environment. Furthermore, an 
injection of saline administered 3-4 days follow- 
ing repeated AMPH treatment did not produce 
stereotyped behavior. This is in agreement with 
previous suggestions that drug-environment con- 
84 
ditioning is not necessary for the development of 
sensitization 12'15'2°'55"65"67 (also ref. 59 for 
review). Nevertheless, efforts were made to 
minimize drug-environment conditioning in the 
present study, and the long-term effects of 
repeated AMPH treatment may be greatly poten- 
tiated if appropriate drug-environment contingen- 
cies are established (e.g. ref. 70). 
Neural correlates of behavioral sensitization 
AMPH-pretreatment significantly enhanced 
striatal HVA concentrations and DA metabolite 
to DA ratios in intact female, GDX female and 
GDX male rats, but not intact male rats. Thus, 
those groups which showed the most robust be- 
havioral sensitization also showed changes in 
striatal DA metabolism; whereas intact male ani- 
mals showed less pronounced behavioral changes 
and no significant changes in DA metabolism. In 
some experimental situations DA metabolism 
may provide a sensitive index of DA utili- 
zation 8'4°'71. Therefore, to the extent that an ele- 
vation in HVA levels and DA metabolite to DA 
ratios indicates increased DA utilization, AMPH 
pretreatment may have enhanced DA utilization 
preferentially in those groups showing the most 
robust behavioral changes. This interpretation 
must be considered preliminary, however, 
because in some situations DA metabolism can 
be dissociated from DA utilization or release (e.g. 
ref. 17). But regardless of the interpretation of 
changes in DA metabolism, the results do show 
for the first time that the effects of sex and gonadal 
hormones on at least one neurochemical correlate 
of sensitization are consistent with their effects on 
behavioral sensitization (also see ref. 15). 
The failure of repeated AMPH treatment to 
change basal levels of striatal DA metabolism or 
DA utilization in intact males has been reported 
previously l s,39,47,50. This raises the question: if an 
enhancement in striatal DA utilization/release is 
causally related to the development of behavioral 
sensitization, why do both males and females 
show behavioral sensitization (albeit males to a 
lesser degree) but only females and GDX males 
show evidence of increased striatal DA utiliza- 
tion? There are a number of possible answers to 
this question. One possibility is that enhanced 
striatal DA utilization/release is not causally 
related to behavioral sensitization. However, 
AMPH-stimulated striatal DA utilization/release 
is enhanced in both male 37'5°'58 and female rats 
pretreated with AMPH 16'61. Therefore, behav- 
ioral sensitization is accompanied by enduring 
changes in striatal DA release in both males and 
females, but such changes may not be obvious in 
the absence of a subsequent challenge stimulus. 
Perhaps under basal conditions the changes in 
striatal DA activity produced by prior AMPH 
treatment are minimal and only apparent in the 
most highly sensitized groups. 
Another factor that may contribute to the dif- 
ferences between intact male animals and the 
other 3 groups is suggested by the analysis of 
subgroups. Following repeated AMPH treatment 
intact males were divisible into two neurochemi- 
cally distinguishable subgroups. One subgroup 
was highly sensitized, as indicated by the emer- 
gence of a multiphasic pattern of AMPH-induced 
behavior, characterized in part by highly focused 
stereotypy 6v. The other subgroup did not develop 
this multiphasic pattern of behavior, and was thus 
presumably less sensitized. The former subgroup 
had significantly higher DOPAC/DA ratios than 
the latter. In contrast, it was not possible to sub- 
divide the intact female, GDX female or GDX 
male groups into two neurochemically distinct 
subgroups in this fashion. This suggests that the 
intact male population is in some sense more 
heterogeneous than the other 3 populations (also 
see Camp and Robinson15). This greater hetero- 
geneity may make it more difficult to identify 
neurochemical correlates of behavioral sensiti- 
zation in intact males than in females or GDX 
males. It is interesting to speculate that individual 
differences in circulating androgens contribute to 
individual differences in the susceptibility to sen- 
sitization, and that HI activity males have lower 
concentrations of androgens than LO activity 
males. 
Evidence that repeated intermittent AMPH 
treatment produces changes in neural systems 
other than the nigrostriatal DA system is quite 
limite& 9"6°. In the present study there were indi- 
cations that striatal and nucleus accumbens sero- 
tonin metabolism was enhanced by AMPH pre- 
treatment. Although this observation needs to be 
replicated, it is consistent with an earlier report of 
increased [3H]serotonin release into the lateral 
ventricles in AMPH-pretreated rats  69. There is 
much more evidence for sensitization-related 
increases in nucleus accumbens DA utili- 
zation/release, especially following a subsequent 
challenge stimulus 2~'31-33'3s'5°'56. As with the 
striatum, reports of sensitization-related changes 
in basal nucleus accumbens DA activity are 
rare TM. As discussed above, however, this may be 
because less highly sensitized and more variable 
male animals have been used in most studies. 
AMPH pretreatment d i d  significantly enhance 
nucleus accumbens DA metabolite concentra- 
tions in females (also see ref. 63). 
Relations between the sensitization to A M P H  and 
stress 
It has been suggested that the enduring changes 
in brain and behavior produced by repeated inter- 
mittent AMPH treatment may not be unique to 
the psychopharmacology of AMPH,  but due to its 
action as a stressor 1'2'3"52. This idea is supported 
by evidence for 'cross-sensitization' between 
AMPH and stress. That is, prior exposure to a 
variety of stressors enhances the behavioral and 
neurochemical effects of subsequent AMPH 
t rea tment  3,4,28,57,77, and prior exposure to AMPH 
enhances behavioral and neurochemical effects of 
subsequent  stress 4,62. 
In the present study it was hypothesized that if 
AMPH and stress are interchangeable in pro- 
ducing sensitization, then sex and gonadal hor- 
mones should have similar effects on the sensiti- 
zation produced by either 'agent'. The results 
support this hypothesis. Intact females, GDX 
females and GDX males, but not intact males, 
showed a significant enhancement in AMPH- 
induced stereotypy after only 5 days of restraint 
stress, as indicated by ratings of overall stereotypy 
and repetitive head and limb movements. As with 
the sensitization to AMPH, the differences 
between males and females appear to be quantita- 
tive, not qualitative, because 15 days of restraint 
stress enhanced these same responses in intact 
males. We are aware of only one other study in 
which the influence of sex and gonadal hormones 
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on sensitization to repeated intermittent stress 
was examined (refs. 26, 27 for review), but the 
pattern of results is very similar to that reported 
here. Hennessy etal. 26 found that previous 
footshock experience enhanced the elevation in 
corticosterone produced by subsequent foot- 
shock in intact female, GDX female and GDX 
male mice, but not in intact male mice. Thus it 
appears that circulating male, but not female 
gonadal hormones attenuate the sensitization 
produced by either repeated AMPH treatment or 
repeated stress. 
In summary, it was found that: (1)females 
show more robust behavioral sensitization to 
AMPH than males, and prior AMPH treatment 
produces an enduring enhancement in basal 
striatal and nucleus accumbens DA metabolism 
in females, but not males. These results confirm 
and extend our earlier findings 15,55,61,63. (2) This 
sex difference appears to be due to the attenuation 
of sensitization by endogenous testicular hor- 
mones, because GDX of female rats had no effect 
on sensitization, whereas GDX of males en- 
hanced behavioral sensitization and a neuro- 
chemical correlate of sensitization. (3)Males 
appear to be a more heterogeneous population 
than females or GDX animals, because it was 
possible to subdivide the intact male group into 
two neurochemically distinct subgroups based on 
degree of sensitization. The other 3 groups were 
not divisible in this fashion. (4)Prior restraint 
stress also enhanced the behavioral response to 
subsequent AMPH treatment, and sex and testi- 
cular hormones modulated the sensitization to 
stress in the same fashion as sensitization to 
AMPH. It is concluded that individual differ- 
ences in the susceptibility to sensitization by 
either AMPH or stress may be in part due, either 
directly, or indirectly to individual differences in 
the concentration of circulating androgens. 
Whether the effects of sex and gonadal hormones 
described here are related to sex differences in 
psychiatric disorders that can be precipitated by 
AMPH or stress, and are thought to involve brain 
DA dysfunction, is unknown (e.g. refs. 
9,10,29,42,43,75,76). Nevertheless, the data sug- 
gest that studies on the interaction between 
biological and environmental factors contributing 
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to individual variation in the susceptibility to sen- 
sitization will be valuable in trying to understand 
what makes some individuals very sensitive, and 
others quite resistant, to the psychotogenic effects 
of stimulant drugs and stress. 
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